Literature DB >> 22169808

Perspective: A model disease.

William Matsui1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22169808      PMCID： PMC4339071          DOI： 10.1038/480S58a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

Review 1.  Genomics in multiple myeloma.

Authors:  Nikhil C Munshi; Hervé Avet-Loiseau
Journal:  Clin Cancer Res       Date:  2011-03-15       Impact factor: 12.531

Review 2.  Concise review: Emerging concepts in clinical targeting of cancer stem cells.

Authors:  Zeshaan A Rasheed; Jeanne Kowalski; B Douglas Smith; William Matsui
Journal:  Stem Cells       Date:  2011-06       Impact factor: 6.277

Review 3.  Multiple myeloma cancer stem cells.

Authors:  Carol Ann Huff; William Matsui
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

Review 4.  Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment.

Authors:  Constantine S Mitsiades; Nicholas S Mitsiades; Paul G Richardson; Nikhil C Munshi; Kenneth C Anderson
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429
  4 in total
  6 in total

1.  A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.

Authors:  Barbara Muz; Pilar de la Puente; Feda Azab; Micah John Luderer; Justin King; Ravi Vij; Abdel Kareem Azab
Journal:  Br J Haematol       Date:  2016-01-05       Impact factor: 6.998

2.  PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells.

Authors:  Miao Li; Fangfang Shi; Xiong Fei; Songyan Wu; Di Wu; Meng Pan; Shouhua Luo; Ning Gu; Jun Dou
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

3.  Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment.

Authors:  Matthieu C J Bosman; Carlos R Reis; Jan J Schuringa; Edo Vellenga; Wim J Quax
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

4.  Hypoxia promotes stem cell-like phenotype in multiple myeloma cells.

Authors:  B Muz; P de la Puente; F Azab; M Luderer; A K Azab
Journal:  Blood Cancer J       Date:  2014-12-05       Impact factor: 11.037

5.  Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles.

Authors:  Fangfang Shi; Miao Li; Jing Wang; Di Wu; Meng Pan; Mei Guo; Jun Dou
Journal:  Stem Cell Res Ther       Date:  2018-05-21       Impact factor: 6.832

6.  Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice.

Authors:  Cuiping Yang; Jing Wang; Dengyu Chen; Junsong Chen; Fei Xiong; Hongyi Zhang; Yunxia Zhang; Ning Gu; Jun Dou
Journal:  Int J Nanomedicine       Date:  2013-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.